TXN and acute myeloid leukemia: Interactions between thioredoxin (TRX) and the c-Jun stimulation domain-binding protein-1 (JAB1) mediated by reactive oxygen species (ROS) are pivotal in the pathobiology and recurrence of AML subtype M5 (AML-M5) [44].